Teflurane (INN, USAN, code name Abbott 16900) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1][2] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of halopropane and norflurane.[3]
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C2HBrF4 |
| Molar mass | 180.928 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Chemistry
editTeflurane is 2-bromo-1,1,1,2-tetrafluoroethane, a haloalkane. It is a gas at standard conditions.[4] The compound is chiral.
See also
editReferences
edit- ^ Klein SL (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4.
- ^ Artusio JF, Mazzia VD (1962). Practical anesthesiology. Mosby. ISBN 9780608393322.
- ^ Stanley TH, Petty WC (6 December 2012). Anesthesia, The Heart and the Vascular System: Annual Utah Postgraduate Course in Anesthesiology 1987. Springer Science & Business Media. pp. 185–. ISBN 978-94-009-3295-1.
- ^ "2-Bromo-1,1,1,2-tetrafluoroethane". Chem Spider.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |